DWS Health and Wellness FundSUHAX
Type
Mutual fund
Peer group
US equity: Healthcare
Net assets
$258.8M
Expense ratio
1.33%
1-year return
+6.2%
3 years, a year
+9.4%
5 years, a year
+6.2%
Holdings
64
What it aims to do.
The fund seeks long-term growth of capital.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co | 12.82% |
| JNJ Johnson & Johnson | 6.11% |
| UNH UnitedHealth Group Inc | 4.79% |
| ABBV AbbVie Inc | 4.68% |
| MRK Merck & Co Inc | 4.53% |
| JOBY AstraZeneca PLC | 3.82% |
| TMO Thermo Fisher Scientific Inc | 3.28% |
| BSX Boston Scientific Corp | 3.00% |
| AMGN Amgen Inc | 2.97% |
| SYK Stryker Corp | 2.96% |
More on SUHAX.
- SUHAX overview
- SUHAX holdings
- SUHAX risk
- SUHAX costs
- SUHAX money in and out
- SUHAX share classes
- Compare SUHAX with other funds
Returns after fees, from the fund's SEC filings up to Feb 2026. Past returns are not a promise. Not financial advice.